In a $21.4 billion deal, General Electric will narrow its portfolio by selling its biopharma business to Danaher, a Washington, D.C.-based corporation that has become a larger player in life sciences over the past few years through acquisitions.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,